Daily News Podcast

Valsartan cancer risk is low


 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Bundle pay plan didn’t save money
MDedge Internal Medicine
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Internal Medicine
Is fibromyalgia one disorder – or two?
MDedge Internal Medicine
Is fish oil’s heart benefit a fish tale?
MDedge Internal Medicine
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Internal Medicine
Blood pressure meds cut cognitive impairment risk
MDedge Internal Medicine
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Internal Medicine
Oral drug seen preventing angioedema attacks
MDedge Internal Medicine
Various soft tissue recovery methods get different results
MDedge Internal Medicine
Free skin cancer screening highlights need
MDedge Internal Medicine